Multimodal Imaging Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 5.20 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Multimodal Imaging Market Analysis
The multimodal imaging market was expected to expand with a CAGR of nearly 5.2% during the forecast period. The major factors attributing to the growth of the multimodal imaging market are the growing incidence of chronic diseases like cancer, cardiac disorders, etc., and the increasing geriatric population globally.
According to the United Nations, the number of people aged above 60 years is expected to double by the year 2050, rising from 962 million globally in 2017 to 2.1 billion in 2050. Furthermore, the advancements in the diagnostic imaging, like using artificial intelligence in CT scans and growing health expenditure is a constructive sign for any medical device market including multimodal imaging systems, the adoption of advanced tools and equipment comprising multimodal imaging systems for diagnostics and research applications is growing in developing regions, which drive the market growth.
However, the high cost of multimodal imaging systems and lack of appropriate healthcare infrastructure are the factors restraining the market.
Multimodal Imaging Market Trends
This section covers the major market trends shaping the Multimodal Imaging Market according to our research experts:
PET/CT Systems Segment is Expected to be the Fastest Growing Segment During the Forecast Period
PET scan can be used to inspect the blood flow, oxygen intake, or the metabolism of organs and tissues. PET scans reveal problems at the cellular level, giving the best view of complex systemic diseases. It is majorly used to detect malignancies.
The PET/CT systems segment is expected to be the fastest-growing segment of the multimodal imaging techniques market. This can be credited to the increasing demand for early and accurate cancer diagnosis, expanding clinical evidence for the early diagnosis of Alzheimer's disease, increasing the use of PET/CT systems in cardiology, and many other diseases. Furthermore, good reimbursement situations and technological improvements in the field of PET/CT are a few other reasons for the segment to lead the market.
North America Dominates the Market and Expected to do Same in the Forecast Period
North America is expected to dominate the overall multimodal imaging market, throughout the forecast period. The market growth is due to factors such as the high prevalence of chronic diseases like cancer, cardiovascular diseases in the region, and well-established insurance policies and the availability of advanced healthcare infrastructure are some of the key factors accountable for its large share in the market.
In the North America region, the United States holds the largest market share due to factors such as an increasing number of geriatric populations, a large patient pool in the country, is anticipated to stimulate the demand in this region. According to the American Cancer Society, about 606,880 Americans are expected to die of cancer in 2019, which means 1,660 deaths per day. With the growing incidence of chronic diseases and due to the rapid adoption of technologically advanced imaging systems, the market flourishes in the region.
Multimodal Imaging Industry Overview
The multimodal imaging market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are GE Healthcare, Siemens Healthineers, Koninklijke Philips N.V., Mediso Ltd., Neusoft Medical Systems Co., Ltd., Spectrum Dynamics Medical and others.
Multimodal Imaging Market Leaders
-
GE Healthcare
-
Siemens Healthineers AG
-
Koninklijke Philips N.V.
-
Mediso Ltd.
-
Spectrum Dynamics Medical
*Disclaimer: Major Players sorted in no particular order
Multimodal Imaging Market Report - Table of Contents
-
1. INTRODUCTION
-
1.1 Study Deliverables
-
1.2 Study Assumptions
-
1.3 Scope of the Study
-
-
2. RESEARCH METHODOLOGY
-
3. EXECUTIVE SUMMARY
-
4. MARKET DYNAMICS
-
4.1 Market Overview
-
4.2 Market Drivers
-
4.2.1 Growing Prevalence of Chronic Illness
-
4.2.2 Technological Advancements in Diagnostic Imaging Modalities
-
-
4.3 Market Restraints
-
4.3.1 High Cost of Multimodal Imaging Systems
-
4.3.2 Shortage of Adequate Healthcare Infrastructure
-
-
4.4 Porter's Five Force Analysis
-
4.4.1 Threat of New Entrants
-
4.4.2 Bargaining Power of Buyers/Consumers
-
4.4.3 Bargaining Power of Suppliers
-
4.4.4 Threat of Substitute Products
-
4.4.5 Intensity of Competitive Rivalry
-
-
-
5. MARKET SEGMENTATION
-
5.1 By Technology
-
5.1.1 PET/CT Systems
-
5.1.2 SPECT/CT Systems
-
5.1.3 PET/MR Systems
-
5.1.4 Others
-
-
5.2 By Application
-
5.2.1 Oncology
-
5.2.2 Ophthalmology
-
5.2.3 Cardiology
-
5.2.4 Others
-
-
5.3 By End-User
-
5.3.1 Hospitals
-
5.3.2 Diagnostic Centers
-
5.3.3 Others
-
-
5.4 Geography
-
5.4.1 North America
-
5.4.1.1 United States
-
5.4.1.2 Canada
-
5.4.1.3 Mexico
-
-
5.4.2 Europe
-
5.4.2.1 Germany
-
5.4.2.2 United Kingdom
-
5.4.2.3 France
-
5.4.2.4 Italy
-
5.4.2.5 Spain
-
5.4.2.6 Rest of Europe
-
-
5.4.3 Asia-Pacific
-
5.4.3.1 China
-
5.4.3.2 Japan
-
5.4.3.3 India
-
5.4.3.4 Australia
-
5.4.3.5 South Korea
-
5.4.3.6 Rest of Asia-Pacific
-
-
5.4.4 Middle-East and Africa
-
5.4.4.1 GCC
-
5.4.4.2 South Africa
-
5.4.4.3 Rest of Middle-East and Africa
-
-
5.4.5 South America
-
5.4.5.1 Brazil
-
5.4.5.2 Argentina
-
5.4.5.3 Rest of South America
-
-
-
-
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
-
6.1.1 GE Healthcare
-
6.1.2 Siemens Healthineers
-
6.1.3 Koninklijke Philips N.V.
-
6.1.4 Mediso Ltd.
-
6.1.5 Neusoft Medical Systems Co. Ltd
-
6.1.6 Spectrum Dynamics Medical
-
6.1.7 MILabs B.V.
-
6.1.8 Bruker Corporation
-
- *List Not Exhaustive
-
-
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Multimodal Imaging Industry Segmentation
As per the scope of the report, multimodal imaging systems describe to concurrent production of signals from more than one imaging technique. Multimodal imaging facilitates analyzing more than one molecule at a time so that cellular processes can be analyzed at the same time or the progression of these events can be monitored in present.
| By Technology | |
| PET/CT Systems | |
| SPECT/CT Systems | |
| PET/MR Systems | |
| Others |
| By Application | |
| Oncology | |
| Ophthalmology | |
| Cardiology | |
| Others |
| By End-User | |
| Hospitals | |
| Diagnostic Centers | |
| Others |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Multimodal Imaging Market Research FAQs
What is the current Multimodal Imaging Market size?
The Multimodal Imaging Market is projected to register a CAGR of 5.20% during the forecast period (2024-2029)
Who are the key players in Multimodal Imaging Market?
GE Healthcare, Siemens Healthineers AG, Koninklijke Philips N.V., Mediso Ltd. and Spectrum Dynamics Medical are the major companies operating in the Multimodal Imaging Market.
Which is the fastest growing region in Multimodal Imaging Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Multimodal Imaging Market?
In 2024, the North America accounts for the largest market share in Multimodal Imaging Market.
What years does this Multimodal Imaging Market cover?
The report covers the Multimodal Imaging Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Multimodal Imaging Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Multimodal Imaging Industry Report
Statistics for the 2024 Multimodal Imaging market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Multimodal Imaging analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
